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BACKGROUND: Hyperamylasemia can be observed anecdotally 
during the course of severe sepsis or septic shock. This study 
aimed to investigate the possibility of pancreatic involvement 
in patients with septic shock using serum pancreatic enzyme 
determinations and imaging techniques in 21 consecutive 
patients with septic shock and 21 healthy subjects as controls. 
METHODS: The serum activity of pancreatic amylase and 
lipase was assayed initially in all subjects and 24 and 48 hours 
after the initial observation in the 21 patients with septic shock. 
All patients also underwent radiological examination to detect 
pancreatic abnormalities.
RESULTS: The serum activity of pancreatic amylase was 
significantly higher in the 21 patients with septic shock 
than in the 21 control subjects during the study period, 
while the serum activity of lipase was similar to that of 
the control subjects. Amylase and lipase serum activity 
did not significantly changed throughout the study period 
in the 21 patients with septic shock. None of the patients 
with pancreatic hyperenzymemia had clinical signs or 
morphological alterations compatible with acute pancreatitis. 
CONCLUSION: The presence of pancreatic hyperenzymemia 
in septic shock patients is not a biochemical manifestation 
of acute pancreatic damage, and the management of these 
patients should be dependent on the clinical situation and not 
merely the biochemical results.
(Hepatobiliary Pancreat Dis Int 2011; 10: 191-195)
KEY WORDS: amylase;
                              lipase;
                              clinical medicine;
                              shock;
                              sepsis;
                              systemic inflammatory response syndrome
Introduction
It  has  been  reported  that  amylase  seems  to  be more  frequently  elevated  than  lipase  in  patients with  shock;  however,  none  of  these  patients  with 
pancreatic  hyperenzymemia  had  pancreatic  alterations 
on  imaging.[1]  In  addition,  the  occurrence  of  acute 
pancreatitis  has  rarely  been  reported  after  an  episode 
of  septic  shock,[2,  3]  and  hyperamylasemia  has  also 
been  observed  anecdotally  during  the  course  of  severe 
sepsis[4]  or  septic  shock.[5]  In  our  previous  study 
evaluating the frequency of pancreatic hyperenzymemia 
and acute pancreatitis,[1] only 3 of 12 patients had septic 
shock.  Thus  we  aimed  to  investigate  the  possibility  of 
pancreatic involvement in patients with septic shock by 
serum pancreatic  enzyme determinations  and  imaging 
techniques.
Methods
The  study  was  carried  out  in  the  Intensive  Care  Unit 
(ICU) of Sant'Orsola-Malpighi Hospital  (Bologna,  Italy) 
and  was  approved  by  the  local  institutional  review 
board with a priori patient or appropriate proxy consent 
obtained  prior  to  the  participants'  entry  into  the  study 
which was carried out in accordance with the  Declaration 
of Helsinki.
The criteria for the presence of septic shock were the 
presence  of  an  identifiable  site  of  infection  associated 
with  the  presence  of  a  temperature  greater  than  38 ℃ 
or less than 36 ℃; a heart rate greater than 90 beats per 
minute;  a  respiratory  rate  of more  than 20 breaths per 
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(SPSS  Inc.,  Chicago,  IL,  USA)  on  a  personal  computer. 
Two-tailed  P  values  <0.05  were  considered  statistically 
significant.
Results
The  time  course of  amylase  and  lipase  is  shown  in Fig. 
1.  During  the  3-day  study  period,  the  serum  activity 
of  pancreatic  amylase  was  significantly  higher  in  the 
patients with septic shock than  in  the controls. On the 
contrary, the serum activity of lipase was similar to that 
of  the control  subjects. When only patients with  septic 
shock were considered, we found that the serum activity 
of  amylase  and  lipase  did  not  change  throughout  the 
study period.
minute; a white blood cell count >12 000 or <4000/mm3 
and  hypotension  persisting  despite  fluid  resuscitation 
and  requiring  vasopressor  therapy.[6]  The  exclusion 
criteria were patients under 18 years of age, the absence 
of circulating leukocytes, severely immunocompromised 
patients,  autoimmune  diseases,  active  chemotherapy 
or  chronic  steroid  therapies.[7]  Acute  pancreatitis  was 
diagnosed  on  the  basis  of  the  presence  of  prolonged 
typical  pancreatic  pain  associated with  the  findings  of 





study.  All  patients  were  treated  according  to  current 
therapeutic  modalities,[7]  and  the  final  diagnoses  were 
pneumonia  in  5  patients,  aortic  prosthesis  infection 
in  2,  esophageal  cancer  in  2,  gastric  cancer  in  2, 
pancreatic cancer in 2, jejunal cancer in 1, colon cancer 
in  1,  melanoma  in  1,  chronic  polyneuropathy  in  1, 
osteomyelitis  in  1,  upper  gastrointestinal  tract  injury 




24  hours  from  ICU  admission,  1  within  1  week  from 
ICU  admission,  4  between  the  13th  and  the  18th  day 
from  ICU  admission,  3  between  the  31st  and  the  35th 




donors,  medical  staff  and  subjects  who  underwent  a 




Serum  samples  were  obtained  from  all  subjects  at 




Milan,  Italy;  upper  reference  value,  115 U/L)  and  lipase 
(LIPASE,  Roche, Milan,  Italy;  upper  reference  value,  60 
U/L)  was  assayed  using  commercially  available  kits. 
All  patients  also  underwent  ultrasonography  and/or 
computed tomography to detect pancreatic abnormalities.
Data were expressed as mean±SD. Statistical analyses 
were  carried  out  by  the  Mann-Whitney  U  test,  the 
matched-pairs Wilcoxon's  test  and  the  Spearman's  rank-
order correlation coefficient. The statistical analyses were 
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studied  had  serum  lipase  activity  three  times  greater 
than the upper reference limit. Considering the patients 
who  died  during  hospitalization  and  survivors, we  did 
not  find  significant  differences  in  the  serum  activity 
of  amylase  and  lipase  between  the  survivors  and  non-
survivors in the 3 days of the study (Table).
Pooling  all  the  data  obtained  at  the  different  time 
intervals,  a  significant  relationship was  found  between 
serum amylase and lipase concentrations (P<0.001) (Fig. 
2). This relationship persisted when the determinations 
made  in  the patients  and  control  subjects  (P<0.001  for 
both) were considered separately.
Finally, none of the patients developed clinical signs 
or  morphological  changes  compatible  with  those  of 
acute pancreatitis.
Discussion
One  of  the  consequences  of  septic  shock  is  ischemia, 




In  addition,  microvascular  perfusion  failure  is  a 
characteristic  hallmark  of  pancreatitis.[10-12]  Since 
Panum[13]  presented  the  first  report,  other  researchers 
have  reported  that  the  pancreas  is  highly  sensitive 
to  ischemia.[14-18]  In  humans,  acute  pancreatitis  may 
develop after embolic closure of the vessels supplying the 
pancreas,[19]  after  hypoperfusion  of  the  pancreas  during 
cardiac  surgery[20,  21]  and  surgery  for  thoraco-abdominal 
aneurysms,[22] after splanchnic hypoperfusion,[23] or after 
pancreatic  transplantation.[24]  We  found  that  during  12 
hours  after  admission,  serum  amylase  concentrations 
were  elevated,  whereas  serum  lipase  concentrations 
were  below  the  upper  reference  limit,  suggesting 




we  used  imaging  techniques,  such  as  ultrasonography 
and computed tomography,  in evaluating the changes of 
the  pancreatic  gland,  and  the  pancreatic  changes  were 
not  clinically  relevant.  Interestingly,  hyperamylasemia 
was  also  observed  anecdotally  in  the  course  of  severe 
sepsis[4]  or  septic  shock.[5]  Previously  we  evaluated  the 
frequency  of  pancreatic  hyperenzymemia  and  acute 
pancreatitis,[1]  and  we  found  that  only  3  of  12  patients 
had  septic  shock. Thus  investigated  in  the present  study 
the  possibility  of  pancreatic  involvement  in  patients 
with  septic  shock  using  serum  pancreatic  enzyme 
determinations  and  imaging  techniques. As pointed out 
by  Rogers,[5]  biochemical  investigation  is  no  substitute 
for  clinical  examination.  In  fact,  even  if  the  serum 
activity of pancreatic amylase was significantly higher in 




pancreatitis.  Thus,  other  causes  should  be  hypothesized 
for the increased level of serum amylase. For example, in 
the  present  study,  7  patients  had  gastrointestinal  tract 
diseases and 2 were operated on for a pancreatic neoplasm 
(9/21,  42.9%).  Although  pancreatic  hyperenzymemia 
was  observed  in  these patients, who were  free  from any 
kind  of  contemporary  shock  condition,  we  believe  that 
this evidence does not affect our data because only a low 
percentage of the patients (9.5%) had a serum activity of 





  Initial observation 127±65 226±212 0.756
  24 hours 139±54 176±148 0.603
  48 hours 156±84 171±155 0.941
Lipase
  Initial observation   41±29   54±51 0.973
  24 hours   47±37   39±32 0.503
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reference limit i.e. one patient had upper gastrointestinal 





and  intestinal  obstruction,  and  abdominal  surgery.[26-31] 
However, this was not the case in our patients. Our data 
also agree with those of Vadas et al[32] who found similar 
data  in  septic  shock patients by using phospholipase A2 
determination.  These  authors  reported  that  their  data 
on  phospholipase  A2  levels  were  consistent  with  an 
extrapancreatic source of intravascular phospholipase A2 
release  during  sepsis  and  these  levels  correlated  directly 
with the magnitude and duration of circulatory collapse, 
with  a  progressive  fall  of  serum  PLA2  levels  during 
convalescence.
Finally,  none  of  the  patients  with  septic  shock 
had  serum  lipase  activity  three  times  greater  than  the 
upper  reference  limit.  This  further  confirmed  that 
serum  lipase  is more  accurate  than pancreatic  amylase 
in  the  diagnosis  of  acute  pancreatitis.[33,  34]  It  has  also 
been  reported  that  sepsis  is  associated  with  secretory 
pancreatic  dysfunction  that  is  worse  in  septic  shock 
patients  than  in  sepsis patients without  shock and  that 
impaired  exocrine  function  is  significantly  correlated 
to  APACHE  III  and  SOFA  scores.[35]  However,  these 
findings do not influence the result of our study because 
we  aimed  to  evaluate  the  presence  of  acute  pancreatic 
alterations in patients with septic shock.
Considering patients who died during hospitalization 
and  survivors,  we  found  no  differences  in  the  serum 
activity of amylase and lipase between the survivors and 
non-survivors in the 3 days of the study.
In  conclusion,  during  the  early  phases  of  septic 
shock,  serum amylase  is more  frequently elevated  than 
serum  lipase,  but  none  of  the  patients with  pancreatic 
hyperenzymemia  showed  pancreatic  injury  at  imaging. 
The  presence  of  hyperamylasemia  in  a  patient  with 
septic shock is not a biochemical manifestation of acute 
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